GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spermosens AB (XSAT:SPERM) » Definitions » 3-Year EBITDA Growth Rate

Spermosens AB (XSAT:SPERM) 3-Year EBITDA Growth Rate : 51.70% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Spermosens AB 3-Year EBITDA Growth Rate?

Spermosens AB's EBITDA per Share for the three months ended in Dec. 2024 was kr-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 51.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Spermosens AB was 51.70% per year. The lowest was -124.00% per year. And the median was -36.15% per year.


Competitive Comparison of Spermosens AB's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Spermosens AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spermosens AB's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Spermosens AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Spermosens AB's 3-Year EBITDA Growth Rate falls into.


;
;

Spermosens AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Spermosens AB  (XSAT:SPERM) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Spermosens AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Spermosens AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Spermosens AB Business Description

Traded in Other Exchanges
Address
Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Spermosens AB is developing a revolutionary platform technology for diagnosing male-factor infertility and directing to the right infertility treatment. It is a developer of medical device products for male infertility, individualizing In Vitro Fertilization (IVF) diagnostics and treatment creating a new standard for faster and safer IVF treatments.

Spermosens AB Headlines

No Headlines